FDA inspection

SERIPHARM: FDA inspection ending Jan 29, 2010

FDA inspection 646917 · Voluntary Action Indicated (VAI) · Le Mans

Key facts

Inspection ID 646917
Firm SERIPHARM
FEI number 3002808119
Address Technopole Universite, 1 rue Democrite
City Le Mans
Country France
Fiscal year 2010
Inspection end date Jan 29, 2010
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections